Search
for

    Glossary M phase

    stage where a cell divides into two identical cells

    The M phase, also known as the Mitotic phase, is a stage in the cell cycle where a single cell divides to produce two identical daughter cells. This phase includes both mitosis (the division of the cell's nucleus) and cytokinesis (the division of the cell's cytoplasm), ensuring that each daughter cell receives an exact copy of the parent cell's genetic material.

    Related Terms

    Sort by

    Community Join

    30 / 1000+ results

      community VDPHL01 phase-2/3 results comparison

      in Research/Science  128 upvotes 4 months ago
      The conversation discusses hair loss treatments, focusing on a new slow-release oral minoxidil compared to topical minoxidil and finasteride. The results show that twice-daily dosing of the new treatment is slightly more effective than once-daily, but concerns about cost, side effects, and the accuracy of reported results remain.

      community What time between shedding phases?

      in Treatment  1 upvotes 1 year ago
      The user is using Dutasteride, Minoxidil, microneedling, RU58841, and tretinoin for hair loss. They are experiencing shedding but notice new hair growth and are curious about the timing of future shedding phases.

      community Shedding phase... It's brutal lol

      in Progress Pictures  8 upvotes 4 months ago
      The user is using finasteride and topical minoxidil for hair loss after previously trying them separately without success. They are experiencing a shedding phase but are committed to the treatment.

      community Breezula Phase 3 confusion - did they change something?

       8 upvotes 7 months ago
      Breezula's phase 2 showed reduced efficacy after 6 months, but phase 3 had positive results, causing confusion about any changes made to the drug. There is frustration over the long timeline for hair loss treatments, with some users expressing more interest in other potential treatments like GT-20029.

      community Phase 3 Study for PP405 officially posted

       43 upvotes 1 day ago
      PP405 is in a phase 3 trial for hair loss treatment, with the study expected to run until June 2028. Minoxidil and finasteride remain key treatments, with hopes for PP405 to offer a new mechanism of action.

      community Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026

       171 upvotes 2 days ago
      Pelage Pharmaceuticals is starting Phase 3 trials for PP405 in September 2026, with potential market release by 2030. Users discuss various hair loss treatments like minoxidil, finasteride, RU58841, kx, breezula, and gt20029, expressing hope for future hair restoration.

      community M(23) 5 months of using Fin and Min

       69 upvotes 4 months ago
      A 23-year-old has been using finasteride every other day and topical minoxidil daily for five months to address hair thinning, with plans to resume dermarolling. They experienced minimal shedding and are considering switching to daily finasteride for better results.

      community Pyrilutamide phase III clinical trial results released

      in Research/Science  31 upvotes 2 years ago
      Pyrilutamide did not show effectiveness in regrowing hair compared to a placebo, but it may still help maintain existing hair by preventing DHT from causing follicle miniaturization. Some users believe it could be beneficial when used with other treatments like minoxidil, finasteride, and dutasteride.

      community Third shedding phase on less than 6 months of treatment

      in Chat  7 upvotes 3 months ago
      The user has been using minoxidil for almost 6 months and finasteride for almost 4 months, experiencing significant shedding and minimal stabilization. They are considering switching to dutasteride if no improvements are seen and are advised to be patient, as results may take up to 2 years.

      community 21 M - 6 months on 1mg Finasteride every day

      in Progress Pictures  120 upvotes 5 months ago
      A 21-year-old male shared progress pictures after 6 months of using 1mg finasteride daily, reporting no side effects and noticeable improvement. The user got finasteride prescribed and did not mention using it in combination with minoxidil.

      community How bad is the shed phase really?

      in Chat  6 upvotes 5 months ago
      The shed phase from using finasteride and minoxidil can vary, with some experiencing noticeable hair loss and others having minimal shedding. Despite initial shedding, many users report eventual hair regrowth and improvement, making the treatment worthwhile.

      community Petition Alert: Let's Get PP405 Phase 3 Trials in Germany by 2026!

       55 upvotes 1 year ago
      A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.

      community This shedding phase is brutal man…

       590 upvotes 1 year ago
      The user is experiencing a difficult shedding phase after starting a hair loss treatment with oral finasteride, topical minoxidil, and microneedling. Despite the shedding, they remain hopeful for regrowth and plan to continue the treatment, encouraged by others' positive results.

      community i'm Considering adding hair stimulant: stemoxydine or alphatradiol

       5 upvotes 1 year ago
      The user is considering adding Stemoxydine to their hair loss regimen, as they already use topical finasteride with rosemary and cannot use Minoxidil. They are seeking feedback on Stemoxydine and Alphatradiol, and another user mentions 2-deoxy-d-ribose as a potential option.

      community Verteporfin Phase 1 Human Clinical Trial In The Works - Research

       92 upvotes 1 year ago
      Verteporfin is being discussed for its potential to regrow hair and heal scars, possibly aiding hair transplants or replacing them. Some users are skeptical about its effectiveness, while others suggest combining it with microneedling for better results.

      community Breezula phase 3 results said to be released next month

       26 upvotes 1 year ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

       124 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community 21 M Planning trip to Turkey for FUE

       4 upvotes 9 years ago
      A 21-year-old is considering a hair transplant in Turkey due to aggressive hair loss and scalp psoriasis, but is advised to try finasteride and minoxidil for at least a year to stabilize hair loss before proceeding. The user is concerned about side effects but plans to consult a dermatologist and possibly start finasteride.

      community (23 M) On the verge of depression

       4 upvotes 2 weeks ago
      A 23-year-old male is experiencing severe hair loss and depression, using minoxidil but hesitant to start finasteride due to fear of side effects. Others suggest starting finasteride, noting it takes time to show results, and mention that it is available over-the-counter in Pakistan.

      community Breezula Phase III 12-Month Data Released by Cosmo Pharma

       42 upvotes 5 months ago
      Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.